Dr. D. Berwouts, Nucleaire Geneeskunde SRL
Dr. D. Berwouts, Nucleaire Geneeskunde reported total assets of 749,586 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
By total assets for 2025, Dr. D. Berwouts, Nucleaire Geneeskunde ranks among the 5,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. D. Berwouts, Nucleaire Geneeskunde shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +45 % Total assets -13 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. D. Berwouts, Nucleaire Geneeskunde's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 428,867 € | ||||
| Equity | 493,394 € | ||||
| Cash | 375,516 € | ||||
| EBITDA | 582,954 € | ||||
| Total assets | 749,586 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jun 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
- Year ended 31 Dec 2021filed on 25 Apr 2022
Dr. D. Berwouts, Nucleaire Geneeskunde's financial analysis
- Solvency65.8%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. D. Berwouts, Nucleaire Geneeskunde
1 active director(s) in the register.
Dr. D. Berwouts, Nucleaire Geneeskunde's shareholders and holdings →Dr. D. Berwouts, Nucleaire Geneeskunde's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0699.673.272
- VAT number
- BE0699673272
- Peppol
- Registered · 0208:0699673272 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Jul 2018
- Registered office
- 9831 Sint-Martens-Latem
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. D. Berwouts, Nucleaire Geneeskunde (SRL) has been based in Sint-Martens-Latem since 2018, active in: medical specialists activities. For 2025, it reports a net profit of 428,867 € and equity of 493,394 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. D. Berwouts, Nucleaire Geneeskunde
Companies in the same business, of comparable size and area, outside its group.
- Dokter Caenepeel Philip Medical specialists activities Genk · balance sheet 816,229 €
- Dr. Thomas Botelberge Medical specialists activities Antwerp · balance sheet 881,370 €
- Dr. Els Dufraimont Medical specialists activities Bonheiden · balance sheet 923,556 €
- Mind AF Medical specialists activities Duffel · balance sheet 19 €
- Cabinet Medical Laurence Jeunieaux Medical specialists activities Mons · balance sheet 754,922 €
- Smartortho Medical specialists activities Antwerp · balance sheet 762,595 €
- Dr Anciaux Marc Medical specialists activities Oudenaarde · balance sheet 769,924 €
- Dr. Christophe Verlinden Medical specialists activities Bonheiden · balance sheet 727,447 €
Frequently asked questions about Dr. D. Berwouts, Nucleaire Geneeskunde
What is the revenue of Dr. D. Berwouts, Nucleaire Geneeskunde?
Dr. D. Berwouts, Nucleaire Geneeskunde files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. D. Berwouts, Nucleaire Geneeskunde?
In Belgium, the VAT number is the company number prefixed with BE: BE0699673272 for Dr. D. Berwouts, Nucleaire Geneeskunde, if the company is VAT-registered. Its company number (CBE) is 0699.673.272.
Where is the registered office of Dr. D. Berwouts, Nucleaire Geneeskunde?
According to the CBE register, the registered office of Dr. D. Berwouts, Nucleaire Geneeskunde is in 9831 Sint-Martens-Latem.
What is the equity of Dr. D. Berwouts, Nucleaire Geneeskunde?
At the close of the 2025 financial year, the equity of Dr. D. Berwouts, Nucleaire Geneeskunde amounts to 493,394 €, a solvency of 65.8% of total assets.
Who manages Dr. D. Berwouts, Nucleaire Geneeskunde?
The register lists 1 active mandates at Dr. D. Berwouts, Nucleaire Geneeskunde. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. D. Berwouts, Nucleaire Geneeskunde within its sector?
By total assets for 2025, Dr. D. Berwouts, Nucleaire Geneeskunde ranks among the 5,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Dr. D. Berwouts, Nucleaire Geneeskunde
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →